In South Africa, four specimens from individuals who had travelled to India have tested positive for COVID-19 B.1.617.2 variant,
“Four of the specimens tested positive for B.1.617.2 (two cases from Gauteng and two from KwaZulu-Natal). The B.1.617.2 variant is currently highlighted as a variant of interest by the World Health Organization and is one of multiple variants circulating in India,” National Institute for Communicable Diseases (NICD) said in a statement.
It added that all cases have been isolated and managed according to COVID-19 case management guidelines. Contact tracing has also been performed in order to limit the spread of this variant.
Another variant that is currently dominating COVID-19 infections in Europe and North America, B.1.1.7 has also been detected in South Africa.
Eleven cases of B.1.1.7 have been confirmed, with eight cases in the Western Cape, two cases in Gauteng and one case in KwaZulu-Natal.
“It is not surprising that new variants have been detected in South Africa”, said NICD Acting Executive Director, Professor Adrian Puren.
Head of the Division of Public Health Surveillance and Response at the NICD, Dr Michelle Groome, assured the public that the institute is focusing its resources and research efforts towards understanding the variants and what the potential implications are for South Africa.
Groome added that provincial health authorities remain on high alert and are prioritising the sequencing of COVID-19 positive samples from travellers entering the country, from India specifically and their close contacts.
The institute said minimising the spread of the disease and possibly curtailing a resurgence through compliance with non-pharmaceutical interventions could not be emphasised enough.
“We understand that many are suffering from COVID-19 fatigue, and becoming lax in exercising preventative measures. But for the sake of yourselves and your loved ones, wash or sanitise your hands, wear your masks and maintain physical distance of 1.5 m from others. Remember to hold gatherings outdoors, or in well ventilated areas and roll up your sleeve once the COVID-19 vaccine becomes available to you,” said Puren.
